FcR Therapeutics is developing first-in-class antibody solutions for autoimmune disease.
We believe that our proprietary drug leads can target Fc receptors (FcRs), a specific class of receptors expressed on various immune cells, to provide a major therapeutic perspective for patients suffering from various devastating autoimmune diseases.
We provide proprietary antibody solutions aiming to disrupt the overactive interplay between autoantibodies and Fc receptors resulting in inflammation and tissue damage.
Our therapeutic focus is on autoimmune diseases that can benefit from interfering with derailed Fc-receptor biology by developing a risk-balanced and diverse pipeline of unique proprietary drugs, resulting in potent and safe therapeutic options.
Company Details
- Employees
- 2
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.fcrtherapeutics.com
- Keywords
- UKHR.COM LIMITED.
Fcr Therapeutics Questions
Fcr Therapeutics's website is http://www.fcrtherapeutics.com
Fcr Therapeutics's LinkedIn profile is https://www.linkedin.com/company/fcr-therapeutics
Fcr Therapeutics has
2 employees.
View email and phone details for 2
employees at Fcr Therapeutics.
Fcr Therapeutics's industry is
Biotechnology Research
Fcr Therapeutics's top competitors are
Infusion Nurses Society,
Backstory Insurance,
Rheumatology Nurses Society,
Perception Neuroscience,
Himed International Innovation Center,
Ukhr.com Limited,
Grifols,
Gt Biotech Consultancy,
Resilient Collective,
Nexgen Team.
Fcr Therapeutics's categories are Biotechnology Research
Fcr Therapeutics's founding year is 2024
